119 related articles for article (PubMed ID: 10699380)
1. Caffeine and nicotinamide enhances the aqueous solubility of the antimalarial agent halofantrine.
Lim LY; Go ML
Eur J Pharm Sci; 2000 Mar; 10(1):17-28. PubMed ID: 10699380
[TBL] [Abstract][Full Text] [Related]
2. The antimalarial agent halofantrine perturbs phosphatidylcholine and phosphatidylethanolamine bilayers: a differential scanning calorimetric study.
Lim LY; Go ML
Chem Pharm Bull (Tokyo); 1999 Jun; 47(6):732-7. PubMed ID: 10399830
[TBL] [Abstract][Full Text] [Related]
3. Halofantrine-phospholipid interactions: monolayer studies.
Go ML; Feng SS
Chem Pharm Bull (Tokyo); 2001 Jul; 49(7):871-6. PubMed ID: 11456094
[TBL] [Abstract][Full Text] [Related]
4. Effect of kolanut on the pharmacokinetics of the antimalarial drug halofantrine.
Kolade YT; Babalola CP; Olaniyi AA; Scriba GK
Eur J Clin Pharmacol; 2008 Jan; 64(1):77-81. PubMed ID: 17952423
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in vitro evaluation of solid dispersions of halofantrine.
Abdul-Fattah AM; Bhargava HN
Int J Pharm; 2002 Mar; 235(1-2):17-33. PubMed ID: 11879736
[TBL] [Abstract][Full Text] [Related]
6. Determination of physicochemical properties of halofantrine.
Babalola CP; Adegoke AO; Ogunjinmi MA; Osimosu MO
Afr J Med Med Sci; 2003 Dec; 32(4):357-9. PubMed ID: 15259917
[TBL] [Abstract][Full Text] [Related]
7. A physicochemical basis for the extensive intestinal lymphatic transport of a poorly lipid soluble antimalarial, halofantrine hydrochloride, after postprandial administration to dogs.
Khoo SM; Prankerd RJ; Edwards GA; Porter CJ; Charman WN
J Pharm Sci; 2002 Mar; 91(3):647-59. PubMed ID: 11920750
[TBL] [Abstract][Full Text] [Related]
8. Structural analysis of the antimalarial drug halofantrine by means of Raman spectroscopy and density functional theory calculations.
Frosch T; Popp J
J Biomed Opt; 2010; 15(4):041516. PubMed ID: 20799794
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the lymphatic transport of halofantrine administered in disperse systems containing three different unsaturated fatty acids.
Holm R; Müllertz A; Pedersen GP; Kristensen HG
Pharm Res; 2001 Sep; 18(9):1299-304. PubMed ID: 11683243
[TBL] [Abstract][Full Text] [Related]
10. Effect of a mixture of caffeine and nicotinamide on the solubility of vitamin (B2) in aqueous solution.
Evstigneev MP; Evstigneev VP; Santiago AA; Davies DB
Eur J Pharm Sci; 2006 May; 28(1-2):59-66. PubMed ID: 16483751
[TBL] [Abstract][Full Text] [Related]
11. The influence of lipids on stereoselective pharmacokinetics of halofantrine: Important implications in food-effect studies involving drugs that bind to lipoproteins.
Brocks DR; Wasan KM
J Pharm Sci; 2002 Aug; 91(8):1817-26. PubMed ID: 12115809
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of synthetic beta-haematin and effects of the antimalarial drugs quinidine, halofantrine, desbutylhalofantrine and mefloquine on its formation.
Egan TJ; Hempelmann E; Mavuso WW
J Inorg Biochem; 1999; 73(1-2):101-7. PubMed ID: 10212997
[TBL] [Abstract][Full Text] [Related]
13. The formulation of Halofantrine as either non-solubilizing PEG 6000 or solubilizing lipid based solid dispersions: physical stability and absolute bioavailability assessment.
Khoo SM; Porter CJ; Charman WN
Int J Pharm; 2000 Sep; 205(1-2):65-78. PubMed ID: 11000543
[TBL] [Abstract][Full Text] [Related]
14. A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrine.
Humberstone AJ; Porter CJ; Charman WN
J Pharm Sci; 1996 May; 85(5):525-9. PubMed ID: 8742945
[TBL] [Abstract][Full Text] [Related]
15. Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80.
Lind ML; Jacobsen J; Holm R; Müllertz A
Eur J Pharm Sci; 2008 Oct; 35(3):211-8. PubMed ID: 18675904
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of halofantrine in the rat: stereoselectivity and interspecies comparisons.
Brocks DR; Toni JW
Biopharm Drug Dispos; 1999 Apr; 20(3):165-9. PubMed ID: 10211870
[TBL] [Abstract][Full Text] [Related]
17. Direct determination of the enantiomers of the antimalarial drug halofantrine and its active metabolite N-desbutylhalofantrine in human plasma.
Terefe H; Blaschke G
J Chromatogr B Biomed Appl; 1994 Jul; 657(1):238-42. PubMed ID: 7952076
[TBL] [Abstract][Full Text] [Related]
18. X-ray crystal structure of the antimalarial agent (-)-halofantrine hydrochloride supports stereospecificity for cardiotoxicity.
Karle JM
Antimicrob Agents Chemother; 1997 Apr; 41(4):791-4. PubMed ID: 9087491
[TBL] [Abstract][Full Text] [Related]
19. Thermodynamic origin of the solubility profile of drugs showing one or two maxima against the polarity of aqueous and nonaqueous mixtures: niflumic acid and caffeine.
Bustamante P; Navarro J; Romero S; Escalera B
J Pharm Sci; 2002 Mar; 91(3):874-83. PubMed ID: 11920772
[TBL] [Abstract][Full Text] [Related]
20. In vitro properties of surface-modified solid lipid microspheres containing an antimalarial drug: halofantrine.
Attama AA; Igbonekwu CN
Asian Pac J Trop Med; 2011 Apr; 4(4):253-8. PubMed ID: 21771465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
